Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9607558 | 1.00 | CA1 (0.50) | CA1CA9CYP1A2SMN1; SMN2 | |
| SCHEMBL2664154 | 1.00 | CA1 (0.50) | CA1CA9CYP1A2SMN1; SMN2 | |
| SCHEMBL13533896 | 0.86 | CA1 (0.46) | CA1CA9CYP1A2SMN1; SMN2 | |
| SCHEMBL13817904 | 0.86 | CA1 (0.46) | CA1CA9CYP1A2SMN1; SMN2 | |
| SCHEMBL9927430 | 0.82 | CA1 (0.46) | CA1CA9CYP1A2SMN1; SMN2 | |
| SCHEMBL22972533 | 0.79 | CA1 (0.43) | CA1CA9CYP1A2SMN1; SMN2 | |
| SCHEMBL9559189 | 0.76 | CA1 (0.44) | CA1CA9CYP1A2 | |
| SCHEMBL12182879 | 0.76 | CA1 (0.44) | CA1CA9CYP1A2 | |
| SCHEMBL25327380 | 0.76 | CA1 (0.41) | CA1CA9CYP1A2 | |
| SCHEMBL9436287 | 0.74 | CA1 (0.39) | CA1CA9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120135975-A1 | Substituted Esters as Cannabinoid-1 Receptor Modulators | MERCK & CO., INC. (US) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135975-A1 | Substituted Esters as Cannabinoid-1 Receptor Modulators | CNR1, CNR2, FAAH | CA1 2386/4885CA9 3257/4885CYP1A2 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.